We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 130% above its sector, the market expects faster growth.
Ningbo David Medical Device Co., Ltd. is a global enterprise dedicated to the innovation, production, and worldwide distribution of medical equipment. The company's primary focus lies in providing essential neonatal care devices, such as infant incubators, transport incubators, infant radiant warmers, and phototherapy units for neonatal bilirubin. They also supply infant resuscitators. Beyond these core offerings, Ningbo David Medical Device Co., Ltd. manufactures a diverse range of other medical apparatus. These include infusion pumps, transcutaneous jaundice detectors, infant T-piece resuscitators, air/oxygen blenders, low-pressure aspirators, infant oxygen hoods, far infrared heaters, and infant head-fixing units. All products are marketed under the "David" brand. Established in 1992, the company maintains its headquarters in Ningbo, China.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 300314.SZ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
